HomeCompareMITPF vs VICI

MITPF vs VICI: Dividend Comparison 2026

MITPF yields 8.37% · VICI yields 6.52%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VICI wins by $931.4K in total portfolio value· pulled ahead in Year 2
10 years
MITPF
MITPF
● Live price
8.37%
Share price
$23.90
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$34.8K
Annual income
$1,420.12
Full MITPF calculator →
VICI
VICI Properties Inc.
● Live price
6.52%
Share price
$27.32
Annual div
$1.78
5Y div CAGR
44.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$966.2K
Annual income
$607,376.13
Full VICI calculator →

Portfolio growth — MITPF vs VICI

📍 VICI pulled ahead of the other in Year 2

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMITPFVICI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MITPF + VICI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MITPF pays
VICI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MITPF
Annual income on $10K today (after 15% tax)
$711.30/yr
After 10yr DRIP, annual income (after tax)
$1,207.10/yr
VICI
Annual income on $10K today (after 15% tax)
$554.58/yr
After 10yr DRIP, annual income (after tax)
$516,269.71/yr
At 15% tax rate, VICI beats the other by $515,062.61/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MITPF + VICI for your $10,000?

MITPF: 50%VICI: 50%
100% VICI50/50100% MITPF
Portfolio after 10yr
$500.5K
Annual income
$304,398.12/yr
Blended yield
60.82%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on VICI right now

MITPF
No analyst data
Altman Z
-1.5
Piotroski
3/9
VICI
Analyst Ratings
20
Buy
6
Hold
Consensus: Buy
Price Target
$31.60
+15.7% upside vs current
Range: $30.00 — $33.00
Altman Z
1.4
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MITPF buys
0
VICI buys
0
No recent congressional trades found for MITPF or VICI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMITPFVICI
Forward yield8.37%6.52%
Annual dividend / share$2.00$1.78
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%44.3%
Portfolio after 10y$34.8K$966.2K
Annual income after 10y$1,420.12$607,376.13
Total dividends collected$11.3K$926.2K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: MITPF vs VICI ($10,000, DRIP)

YearMITPF PortfolioMITPF Income/yrVICI PortfolioVICI Income/yrGap
1$11,537$836.82$11,361$941.49+$176.00MITPF
2← crossover$13,247$902.27$13,320$1,481.32$73.00VICI
3$15,142$968.21$16,284$2,405.01$1.1KVICI
4$17,236$1,034.35$21,040$4,071.78$3.8KVICI
5$19,543$1,100.39$29,209$7,285.49$9.7KVICI
6$22,077$1,166.04$44,443$14,006.51$22.4KVICI
7$24,854$1,231.06$75,822$29,512.55$51.0KVICI
8$27,889$1,295.21$148,733$69,726.75$120.8KVICI
9$31,199$1,358.29$344,394$189,413.75$313.2KVICI
10$34,804$1,420.12$966,234$607,376.13$931.4KVICI

MITPF vs VICI: Complete Analysis 2026

MITPFStock

Mithra Pharmaceuticals SA develops, manufactures, and markets complex therapeutics in the areas of contraception, menopause, and hormone-dependent cancers in Europe and internationally. Its development candidates include Estelle, which has completed phase III clinical trial, which is a combined oral contraceptive; Donesta, which is in phase III clinical trial for estetrol-based oral hormone treatment. The company also develops Myring, a contraceptive vaginal ring releasing a combination of hormones; Tibelia, a solution for treating menopause and osteoporosis; and Zoreline, a biodegradable subcutaneous implant for use in prostate and breast cancers, and benign gynecological indications. In addition, it offers NEXTSTELLIS, an oral contraceptive pill. In addition, the company provides products in polymeric forms, implants, sterile injectable products, and hormonal tablets. Mithra Pharmaceuticals SA was founded in 1999 and is headquartered in Liège, Belgium.

Full MITPF Calculator →

VICIREIT

VICI Properties is an experiential real estate investment trust that owns one of the largest portfolios of market-leading gaming, hospitality and entertainment destinations, including the world-renowned Caesars Palace. VICI Properties' national, geographically diverse portfolio consists of 29 gaming facilities comprising over 48 million square feet and features approximately 19,200 hotel rooms and more than 200 restaurants, bars and nightclubs. Its properties are leased to industry leading gaming and hospitality operators, including Caesars Entertainment, Inc., Century Casinos Inc., Hard Rock International, JACK Entertainment and Penn National Gaming, Inc. VICI Properties also owns four championship golf courses and 34 acres of undeveloped land adjacent to the Las Vegas Strip. VICI Properties' strategy is to create the nation's highest quality and most productive experiential real estate portfolio.

Full VICI Calculator →
📬

Get this MITPF vs VICI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MITPF vs SCHDMITPF vs JEPIMITPF vs OMITPF vs KOMITPF vs MAINMITPF vs NNNMITPF vs EPRTMITPF vs ADC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.